This trial will assess the safety and tolerability of a new drug combo in overweight/obese participants, and measure how much of the drug gets into their bloodstream. It will last 11 weeks.
1 Primary · 1 Secondary · Reporting Duration: Predose on Day 1 up to 43 days postdose
2 Treatment Groups
LY3457263 + Tirzepatide
1 of 2
Placebo + Tirzepatide
1 of 2
45 Total Participants · 2 Treatment Groups
Primary Treatment: LY3457263 + Tirzepatide · Has Placebo Group · Phase 1
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Age 20 - 70 · All Participants · 3 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
|Did not meet criteria||100.0%|
Frequently Asked Questions
Is participation in this research open to me?
"In order to be considered for this study, individuals must demonstrate obesity and fall within the 20-70 year old age bracket. There are 45 spots available in total." - Anonymous Online Contributor
Are there still openings for people to join this clinical trial?
"Affirmative. Clinicaltrials.gov presents evidence that this clinical research project, which was initially posted on November 11th 2022, is presently seeking enrollees. Approximately 45 patients need to be enrolled across a single medical centre." - Anonymous Online Contributor
Has the combination of LY3457263 and Tirzepatide obtained regulatory approval?
"As LY3457263 + Tirzepatide is still undergoing its initial trial, there are only a few data points that can serve as evidence of the drug's safety and efficacy. Thus, our team at Power rates it a 1 on their scale from 1 to 3." - Anonymous Online Contributor
Does this experimental study recruit individuals over the age of 40?
"Qualified participants of this experiment must span the ages 20 to 70 inclusive. There are 223 studies open for individuals below the age of majority, and 697 trials available for those over 65 years old." - Anonymous Online Contributor
How many patients are enrolled in this research trial at its current capacity?
"Affirmative. The information available on clinicaltrials.gov confirms that the trial commenced recruitment on November 11th 2022 and is still ongoing, requiring 45 participants from one location." - Anonymous Online Contributor